Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy.
Whelan JS, Davis CL, Rohatiner AZ, Leahy M, MacCallum PK, Gupta RK, Matthews J, Norton AJ, Amess JA, Lister TA. Whelan JS, et al. Among authors: amess ja. Hematol Oncol. 1992 Mar-Apr;10(2):87-94. doi: 10.1002/hon.2900100204. Hematol Oncol. 1992. PMID: 1592366
Acute myeloid leukemia in elderly adults.
Tucker J, Thomas AE, Gregory WM, Ganesan TS, Malik ST, Amess JA, Lim J, Willis L, Rohatiner AZ, Lister TA. Tucker J, et al. Among authors: amess ja. Hematol Oncol. 1990 Jan-Feb;8(1):13-21. doi: 10.1002/hon.2900080103. Hematol Oncol. 1990. PMID: 1688820
Oral idarubicin as a palliative agent in leukemia.
Davis CL, Rohatiner AZ, Amess JA, Lister TA. Davis CL, et al. Among authors: amess ja. Hematol Oncol. 1991 Jan-Feb;9(1):59-60. doi: 10.1002/hon.2900090108. Hematol Oncol. 1991. PMID: 1710595 Clinical Trial. No abstract available.
102 results